Switching from Wellbutrin to Trintellix in a 72-Year-Old with Daily Alcohol Use
In this 72-year-old patient with daily alcohol consumption, taper Wellbutrin by reducing to 150 mg daily for one week before discontinuation, then initiate Trintellix at 5 mg daily (not the standard 10 mg) due to age and alcohol use, with close monitoring for withdrawal symptoms and worsening depression.
Critical Safety Considerations
Alcohol Use and Bupropion
The daily alcohol consumption creates two major concerns:
- Seizure risk: Bupropion lowers seizure threshold, and this risk is amplified by alcohol use and during withdrawal states 1
- Bupropion toxicity can mimic alcohol withdrawal syndrome with agitation, hallucinations, hypertension, and tremors—making clinical assessment challenging 2
Why This Patient Needs Special Caution
At 72 years old with daily alcohol use, this patient faces:
- Higher risk of antidepressant withdrawal symptoms with age and longer treatment duration 3, 4
- Increased suicidality risk monitoring needs, though protective effects are seen in adults ≥65 years 5
- Need for assessment every 1-2 weeks during the transition 6
Wellbutrin Tapering Protocol
For doses of 150 mg/day or higher, reduce to 150 mg daily for one week before full discontinuation 7. While Wellbutrin can be stopped abruptly per FDA labeling 1, the gradual approach is safer in elderly patients with substance use.
Tapering Schedule:
- Week 1: Reduce current dose to 150 mg daily
- Week 2: Discontinue completely
Monitor closely for:
- Withdrawal symptoms (irritability, anxiety, mood changes)
- Worsening depression requiring intervention 6
- Symptoms that could represent either bupropion toxicity or alcohol withdrawal 2
Trintellix Initiation Strategy
Start at 5 mg daily, not the standard 10 mg dose 7. The FDA label explicitly states to "consider 5 mg/day for patients who do not tolerate higher doses," and this elderly patient with daily alcohol use warrants conservative dosing.
Initiation Timing:
You can start Trintellix immediately after stopping Wellbutrin—no washout period is required as there is no pharmacokinetic interaction between bupropion and vortioxetine. In fact, bupropion is a strong CYP2D6 inhibitor that increases vortioxetine exposure 8, so starting vortioxetine at the lower 5 mg dose while any residual bupropion is clearing is prudent.
Dose Titration:
- Weeks 1-2: Trintellix 5 mg daily
- Week 3-4: If tolerated, increase to 10 mg daily
- Week 6+: Consider 20 mg daily if needed for efficacy 7, 9
The meta-analysis shows vortioxetine 20 mg has greater effect size than 10 mg for acute depression 9, but start low in this high-risk patient.
Monitoring Requirements
Weekly visits for the first month are essential 6, 5:
Week 1-2 (During Taper):
- Depressive symptoms and suicidal ideation
- Agitation, irritability, behavioral changes
- Signs of alcohol withdrawal vs. bupropion toxicity
- Blood pressure and tremors
Week 3-4 (Early Trintellix):
- Treatment response using standardized scales
- Nausea (most common Trintellix side effect) 10
- Sexual dysfunction (lower with bupropion, may emerge with vortioxetine) 5
- Continued depression monitoring
Week 6-8:
If inadequate response by 6-8 weeks, modify treatment 6. This is a critical decision point—don't wait longer.
Alcohol Use Management
Address the daily alcohol consumption directly—this significantly impacts treatment success:
- Alcohol reduces antidepressant efficacy
- Increases risk of treatment-emergent adverse events
- While bupropion shows no pharmacokinetic interaction with alcohol 11, the clinical risks remain substantial
- Consider referral for substance use treatment alongside depression management
Common Pitfalls to Avoid
- Don't start Trintellix at 10 mg in this patient—age and alcohol use warrant 5 mg start
- Don't assume symptoms are just depression or alcohol withdrawal—bupropion toxicity presents identically 2
- Don't wait beyond 8 weeks to reassess—guidelines mandate treatment modification by then 6
- Don't ignore the alcohol use—it's central to both safety and efficacy
- Don't stop monitoring after the switch—elderly patients need ongoing assessment for hyponatremia (0.5-12% risk in older adults) 5